Core Viewpoint - The European Union has reached a political agreement on New Genomic Techniques (NGTs), including gene editing, which supports Cibus' plans to enhance plant traits for European growers [1][2][3] Regulatory Framework - The agreed legislative text provides a framework for the development and cultivation of gene-edited plants, addressing intellectual property and seed access [2][4] - This agreement is a significant step towards the formal endorsement of NGT legislation by the European Parliament and Council [2][4] Industry Impact - The agreement signifies the EU's commitment to gene editing technology, facilitating the development of improved plant varieties for the European market [3][6] - Cibus anticipates that this regulatory clarity will enhance opportunities for developing traits in the European market, leveraging successful field trials conducted in the UK [5][6] Product Pipeline - Cibus' product pipeline includes programs aimed at addressing agricultural challenges such as disease resistance and nitrogen use efficiency, which are well-positioned to benefit European growers [7][8] - The company focuses on developing high-value traits for major global row crops, utilizing proprietary gene editing technology to expedite the breeding process [8]
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council